TKI-based regimens remain the primary approach for metastatic renal cell carcinoma after immune checkpoint inhibitor therapy, ...

The narrative emphasizes the critical role of a supportive partner in managing chronic small lymphocytic lymphoma over 16 ...

Higher body mass index (BMI) after diagnosis is linked to better survival outcomes in patients with localized renal cell ...

FOG-001 received fast track designation after early study results showed tumor shrinkage in all evaluable patients with ...

Kidney cancer incidence is 90% higher in American Indian and Alaska Native populations than in non-Hispanic Whites, with mortality rates nearly double. Disparities are driven by late detection, ...

Following the 2025 ESMO Congress, Dr. Joshua Saba sat down with Dr. Chandler Park to discuss recent advances in prostate cancer care.

Dr. Joshua Sabari sat down with Dr. Michael Cecchini to discuss advances in colorectal cancer management and key data ...

The U.S. Food and Drug Administration (FDA) approved Poherdy (pertuzumab-dpzb) as the first interchangeable biosimilar to ...

Cancerguard detects multiple cancers early by identifying specific DNA and protein markers in a blood sample. The test is ...

When Cindy Mrotek and Katie Glenn each became caregivers for their parents with cholangiocarcinoma, they had no idea the ...

Breast cancer advancements include targeted therapies, oral medications for ER-positive/HER2-negative populations, and ...

After her own breast cancer treatment, Maureen advocated for legislation to make scalp cooling more accessible for patients ...